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PURPOSE. To obtain a global perspective on the distribution and
evolution of CYP1B1 mutations in primary congenital glau-
coma (PCG) worldwide.
METHODS. Five intragenic single-nucleotide polymorphisms in
CYP1B1—R48G, A119S, V432L, D449D, and N453S—were used
to generate haplotype data from 138 Indian patients with PCG
and 132 ethnically matched normal controls, which were then
analyzed in conjunction with data from other populations. Maxi-
mum-likelihood estimates of haplotype frequencies were esti-
mated from the genotype data. Subsets of patients and normal
control subjects were also genotyped with respect to eight short
tandem repeat (STR) markers around the CYP1B1 locus (D2S305,
D2S165, D2S367, D2S2259, D2S391, D2S3337, D2S23678, and
D2S286), to gain evolutionary insights.
RESULTS. Common mutations in CYP1B1 that are causal of PCG
occurred on a uniform haplotype background among Indian
patients, which is completely distinct from the modal haplo-
type background found among unaffected control subjects.
Comparison of these data with data from other global regions
reveals strong clustering of CYP1B1 mutations by geographic
and haplotype backgrounds. The two distinct modal haplo-
types found among Indian patients with PCG and control
subjects are both ancient with ages of similar magnitudes, as
indicated by large variances in the number of repeats at eight
STR loci. Together with data from chimpanzee and normal
control subjects from India and other global regions, it was
possible to make a parsimonious reconstruction of the evolu-
tion of these haplotypes.
CONCLUSIONS. The strong association of specific haplotypes
with some predominant CYP1B1 mutations underlying PCG
and the observed geographical clustering, probably due to
founder effects, may be useful for predictive testing. (Invest
Ophthalmol Vis Sci. 2006;47:43–47) DOI:10.1167/iovs.05-
0912
Primary congenital glaucoma (PCG; online Mendelian Inher-itance in Man [OMIM] 231300; http://www.ncbi.nlm.nih
.gov/Omim/searchmorbid/, provided in the public domain by
the National Center for Biotechnology Information, Bethesda,
MD) is a recessively inherited disorder of the eye with variable
penetrance. The trabecular meshwork and anterior chamber
angle of the eye are affected, leading to the obstruction of
aqueous outflow, increased intraocular pressure (IOP) and
optic nerve damage. The onset of this disease is seen in the
neonatal or early infancy period and, if untreated, results in an
irreversible blindness.1 The prevalence of PCG varies across
populations and continents (1/20,000–1/10,000 in Western
populations)2 and is higher in inbred populations (1/2500
among the Saudi Arabians,3 1/1250 among the Slovakian
Roms,2 and 1/3300 among inhabitants of Andhra Pradesh,
India).4 Genetic heterogeneity is well documented in PCG and
three loci on chromosomes 2p21 (GLC3A),5 1p36 (GLC3B),6
and 14q24.3 (GLC3C) (Stoilov IR, et al. IOVS 2002;43:ARVO
E-Abstract 3015) have been identified by linkage analysis. At
the GLC3A locus that harbors the human cytochrome P450
gene CYP1B1 (OMIM 601771), more than 40 different muta-
tions that cause PCG have been identified,7–10 indicating a high
degree of allelic heterogeneity.
Among patients with PCG, the proportion due to CYP1B1
mutations is variable across populations; from 100% among
Saudi Arabians2 and Slovakian Roms,3 to 50% among Brazil-
ians,11 30% in Indonesians,9 and 20% in Japanese.12 The
Slovakian Rom and Saudi Arabian patients with PCG exhibit
allelic homogeneity that has largely been attributed to consan-
guinity and inbreeding.
Five intragenic SNPs in CYP1B1 (GenBank Accession Num-
ber U56438)—3947 C3G (R48G; exon 2), 4160 G3T (A119S;
exon 2), 8131 G3C (V432L; exon 3), 8184 T3C (D449D;
exon 3), and 8195 A3G (N453S; exon 3), have been used to
generate data on haplotypes associated with the mutant chro-
mosomes in a large set of Slovakian Roms,2 Saudi Arabian,3
Brazilian,11 and American patients with PCG.13 All Slovakian
Rom patients possessed a single CYP1B1 mutation (E387K) on
a uniform haplotype (G-T-C-C-A) background.2 A similar sce-
nario was also noted among Saudi Arabian,3 but not among
Indonesian,9 or Japanese12 patients. In the present study, we
generated comparable data from India and analyzed these in
conjunction with data from other populations to obtain a
global perspective on the distribution and evolution of the
CYP1B1-associated PCG mutations.
METHODS
Clinical Details of the Patients
and Control Subjects
The study adhered to the tenets of the Declaration of Helsinki. With
approval of the Institutional Review Board, 138 consecutive patients
with diagnosed PCG and 132 ethnically matched control subjects,
presenting at the L. V. Prasad Eye Institute, Hyderabad, India, from
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January 2001 to May 2004, were recruited with informed consent. The
diagnosis of PCG was confirmed independently by two surgeons based
on clinical examination. In each case of PCG, the eye had an increased
corneal diameter (12.0 mm) with raised IOP (21 mm Hg) and/or
presence of Haab’s striae, or optic disc changes. The ages at onset were
at 0 to 1 year of age and symptoms of epiphora and photophobia were
the corroborating features. Normal adults without any signs or symp-
toms of glaucoma and other systemic diseases served as control sub-
jects. Their visual acuity ranged from 20/20 to 20/40, and IOP was21
mm Hg. Clinical examination on stereo biomicroscopy did not reveal
any changes in the optic disc suggestive of glaucoma. The patients and
control subjects were matched with respect to their geographical
region of habitat.
Molecular Analysis
Peripheral blood samples (5–10 mL) were collected by venipuncture,
and DNA was isolated by standard protocols.14 The entire CYP1B1
gene was bidirectionally resequenced on a DNA analyzer (model 3100;
Applied Biosystems, Inc. [ABI], Foster City, CA) using appropriate
oligonucleotide primers and PCR protocols.15 We have also genotyped
subsets of patients and normal control subjects with respect to eight
short tandem repeat (STR) loci on chromosome 2, around the CYP1B1
locus, to gain evolutionary insights. The order of the STR loci that were
screened is: D2S305, D2S165, D2S367, D2S2259, CYP1B1, D2S391,
D2S337, D2S2368, D2S286. (Intermarker genetic distances are pro-
vided online in Supplementary Table S1 at http://www.iovs.org/cgi/
content/full/47/1/43/DC1.) All the fluorescently labeled STR markers
were amplified on a thermal cycler according to the manufacturer’s
protocol (model 9700; ABI). The amplicons were pooled according to
their dye label and allele size lengths and electrophoresed on the DNA
analyzer. GeneScan software (ABI) was used to score repeats and
genotypings were performed by the Genotyper software (ABI).
Statistical Analysis
When multiple linked loci are considered, although it is not possible to
identify haplotypes at the individual level based on genotype data of a
sample of unrelated individuals, it is possible to estimate statistically
the frequencies of various possible haplotypes possessed by the indi-
viduals in the sample. There are various methods of estimating haplo-
type frequencies in a sample of individuals based on genotype
data.16,17 In this study, maximum-likelihood estimates of haplotype
frequencies were estimated from the genotype data at the five SNP
loci, by using HAPLOPOP software, that uses the EM algorithm.18
RESULTS
In the set of patients with PCG included in this study, 8% had
an affected sibling, whereas the remaining were sporadic. In all
cases, parents were genotyped. An observed nucleotide variant
in a patient was scored as a mutation only when (1) it segre-
gated with the disease phenotype, (2) it was absent in all
normal control subjects, and (3) there was a significant differ-
ence in the minor allele frequencies between the patients and
control subjects. In addition, the wild-type residue was con-
served across different species.
Mutations in CYP1B1 accounted for 44.93% (62/138) of all
cases of PCG. The R368H mutation was the most common,
accounting for 48.38% of mutations. Further details are pro-
vided in Table 1. Seventeen pathogenic mutations in CYP1B1
were observed, of which nine were novel.10,15,19,20 These
novel mutations included three frameshift mutations resulting
from a 23-bp deletion (g.3905del23bp) and a stop codon due to
an insertion of adenine (A) at 30 bp (g.3835) in exon II and a
2-bp deletion (g.7900-7901delCG) in exon III. Five novel mis-
sense mutations—A115P, M132R, Q144P, P193L, and S239R—-
were noted in exon II and one (G466D) in exon III , whose
residue is a part of the signature sequence (NH2-FXXGXXX-
CXG-COOH) and is present in all heme-binding cytochromes.
The spectrum of CYP1B1 mutations is larger in the Indian
population,10 than among Saudi Arabians,3 Slovakian Roms,2
and Brazilians.11 Marked phenotypic heterogeneity in clinical
severity had been observed for these mutations in our earlier
studies.10,15,19
Table 2 provides the estimated frequency distributions of
haplotypes among patients with PCG, classified by the pres-
ence or absence of CYP1B1 mutations, and among unaffected
control subjects. These frequency distributions are signifi-
cantly different (2  64.86, 8 df; P  0.00001; infrequent
TABLE 1. Summary of Observed CYP1B1 Mutations among Patients with PCG in India
CYP1B1 Mutations
(n  62) Homozygous Heterozygous
Compound
Heterozygous
R368H (n  30) 21 (70.00) 6 (20.00) 3 (10.00)
Other mutations (n  32) 23 (71.87) 8 (25.00) 1 (3.12)
Data are the number (% of total).
TABLE 2. Estimated Haplotype Frequencies and Their Standard Deviations among Indian Patients with
PCG and Controls
Haplotype
Patients with PCG
With CYP1B1
Mutations
(n  62)
Without CYP1B1
Mutations
(n  76)
Controls
(n  132)
% SD % SD % SD
C-G-G-T-A 61.67 6.17 21.86 4.74 17.72 3.32
C-G-C-C-A 13.33 4.31 29.32 5.22 23.88 3.71
C-G-C-C-G 4.84 2.72 6.72 2.87 14.32 3.05
G-T-G-T-A 5.27 2.83 8.40 3.18 0.80 2.36
G-T-C-C-A 14.89 4.52 31.86 5.34 42.48 4.30
G-T-C-C-G 0 1.84 1.54 0
C-G-G-T-G 0 0 0.80 2.36
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haplotypes were pooled to avoid vagaries of small sample
sizes). The haplotype frequency distributions among patients
with PCG with CYP1B1 mutations (CYP1B1() subgroup) and
normal subjects were unimodal, whereas in patients without
CYP1B1 mutations (CYP1B1() subgroup) it was bimodal.
Further, the modal haplotypes were different for the
CYP1B1() subgroup (C-G-G-T-A) and control subjects (G-T-C-
C-A). However, the haplotype frequency distributions of the
CYP1B1() subgroup and control subjects were strikingly
similar (Table 2).
There were many striking differences in frequencies of
some haplotypes among the three groups. The C-G-G-T-A hap-
lotype occurred with a high frequency (61.6%) in the
CYP1B1() patient subgroup, which is roughly four times
higher than that in the control subjects (17.8%; Pexact, the
probability for the Fisher exact test 0.00001) and three times
higher than in the CYP1B1() patient subgroup (21.8%; Pexact
 0.00001). The difference in frequencies of this haplotype
between the CYP1B1() subgroup and control subjects is not
statistically significant (Pexact  0.058). The G-T-C-C-A, which
was the modal haplotype (42.3%) among the normal control
subjects, showed a decline in frequency (31.9%) in the
CYP1B1() subgroup of patients, and a further decline
(14.9%) in the CYP1B1() subgroup. These decreases were
statistically significant (both Pexact  0.001). The frequency of
the C-G-C-C-A haplotype among normal subjects and the
CYP1B1() patient subgroup is virtually the same, but is sig-
nificantly lower (Pexact  0.00001) in the CYP1B1() sub-
group.
Table 3 gives the distribution of prevalent CYP1B1 muta-
tions on the background of the four major haplotypes in pa-
tients with PCG worldwide. (Complete lists of prevalent and
minor CYP1B1-associated PCG mutations on the background
of these haplotypes are provided in Supplementary Table S2 at
http://www.iovs.org/cgi/content/full/47/1/43/DC1.) As is evi-
dent from the table, most of the common mutations are clus-
tered on the background of the C-G-G-T-A haplotype. It is
striking that specific mutations are generally present on spe-
cific haplotype backgrounds, irrespective of geographical loca-
tion. For example, a major proportion of the R368H mutation
that is predominant in India occurs on the C-G-G-T-A back-
ground, and it is this same background on which this mutation
is also found in diverse geographical areas such as Saudi Ara-
bia3 and Brazil.11 Similarly, the E387K mutation, which is the
only mutation present among the Slovakian Roms2 appears on
the G-T-C-C-A background and is also found on this same
background in United States13 and Brazil.11 Similar features
also apply to other mutations, such as 4340delG and R390C.
However, it is interesting that although the CYP1B1-associated
PCG mutation E387K occurs predominantly on the G-T-C-C-A
haplotype in many regions of the world, this haplotype is more
strongly associated with the CYP1B1() patient subgroup in
India and also occurs in high frequency among normal individ-
uals (Table 2). It may also be noted that unlike in other
populations, a relatively minor proportion of R368H, M132R,
and E229K mutations occur on multiple haplotype back-
grounds among Indian patients with PCG (Table 3). Because it
is unlikely that a specific haplotype background favors the
recurrence of a specific mutation, this feature is most likely due
to founder effects.
DISCUSSION
We sought to reconstruct this extreme clustering of CYP1B1
mutations on haplotype backgrounds in patients with PCG world-
wide from an evolutionary perspective. The haplotype that is
present among the chimpanzee is G-T-G-C-A (http://www.ensembl
.org/pan_troglodytes/geneview?geneENSPTRG00000011843). TA
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This haplotype has not been found among humans. However, the
common haplotype G-T-C-C-A (Table 2) among normal humans is
only one mutational step away from the chimpanzee haplotype.
This haplotype is obviously an ancient human haplotype. It is
unclear whether there is polymorphism in chimpanzees. How-
ever, another human haplotype C-G-G-T-A is also common, and
the spectrum of CYP1B1 mutations among patients with PCG is
also the highest on this haplotype background (Table 3). Al-
though this haplotype is absent among the Roma patients with
PCG,2 it is present in significantly higher frequencies among the
patients with PCG of Saudi Arabia,3 India, and Brazil11 than in
their normal control subjects (Fig. 1). This haplotype can, there-
fore, be considered an ancient haplotype.
To ascertain whether the ages of the haplotypes C-G-G-T-A
and G-T-C-C-A are of similar magnitudes, we screened 20 indi-
viduals belonging to each of these two haplotypes with respect
to eight STR loci on chromosome 2 (the complete genotype
data of the patients and control subjects at these eight loci are
presented in Supplementary Table S3 at http://www.iovs.org/
cgi/content/full/47/1/43/DC1). The variance in the number of
repeats pooled across the eight loci was approximately four in
both subsets of individuals, indicating that the ages of these
two haplotypes are similar. It is obvious that many of the other
haplotypes are recombination derivatives. For example, the
two haplotypes C-G-C-C-A (Tables 2, 3) and G-T-G-T-A (Table 3)
are best explained as recombination products of the ancestral
haplotypes G-T-C-C-A and C-G-G-T-A. Based on considerations
of parsimony, we have inferred the evolutionary relationships
among the various observed haplotypes associated with the
common CYP1B1 mutations in patients with PCG (Fig. 2). Data
from other geographical regions will be helpful to refine this
scenario.
It is clear from Figure 2, that while the two ancestral
haplotypes are found among both patients and control subjects
(Table 2), the more ancient PCG-related CYP1B1 mutations
occurred on the C-G-G-T-A background, whereas the more
recent mutations occurred on the G-T-C-C-A background (since
the larger fraction of mutations occur on the C-G-G-T-A back-
ground). We, however, note that this inference may be some-
what speculative, but it is not possible to test this speculation
until more extensive data become available from wider geo-
graphical regions.
The strong association of specific haplotypes with some
predominant CYP1B1 mutations underlying PCG and the ob-
served geographical clustering, probably due to founder ef-
fects, may be useful for predictive testing. It is unlikely that the
causal mutations have arisen multiple times during evolution.
The fact that the same mutation is found in multiple geograph-
ical regions is probably because of human population move-
ments. For example, the E387K mutation that is highly preva-
lent among Roma patients with PCG2 is found in low frequency
among patients in the United States13 and Brazil.11 This muta-
tion was probably carried by Roma migrants to the United
States and Brazil—a speculation that is bolstered by its associ-
ation with the same haplotype (G-T-C-C-A) in all three coun-
tries. Similarly, it is known that there have been ancient pop-
ulation movements from the Arabian Peninsula to India.24
Immigrants to India have possibly carried the G61E mutation,
which is highly frequent in Saudi Arabia. This mutation is found
in both countries on the same haplotype (C-G-G-T-A) back-
ground. Unfortunately, the reconstruction of the history of
ancient population movements is very incomplete to permit a
complete explanation of the observed geographical distribu-
tion of the PCG-related CYP1B1 mutations based on historical
gene flow. Identification of mutations in PCG not due to
CYP1B1 and estimates of their frequencies are required from
different geographical regions to generate a clearer and
broader picture of the haplotypic and geographical clustering
of mutations associated with PCG and their evolution.
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